2022 Year in Review: Litigation
Our return to office in 2022 coincided with a year of intense activity in our dispute resolution engagements and other areas of the practice. Wins at trial...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
CRA has a reputation for delivering rigorous analysis and expert testimony. Economic expertise is complemented by experience assisting life sciences companies with business and policy issues. This combination allows CRA to provide effective expert testimony and support.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comOur return to office in 2022 coincided with a year of intense activity in our dispute resolution engagements and other areas of the practice. Wins at trial...
In this Jan-Mar 2023 issue of Corporate Disputes e-magazine, Sean Sheridan, along with other industry professionals, discusses significant developments shaping...
CRA is a proud sponsor of the event. Peter Rankin presents during the session titled “The Next Variant of International Arbitration: Life Sciences.” Jim...
International arbitration is a common mechanism for resolution of the complex, cross-border disputes that can plague global collaborations in life sciences. ...